Table 3.

Laboratory findings of the WD patients at time of diagnosis and at the end of the study.

Variable	No. of Patients	N	mean	std	median	Min	max
Hb(g/dl)	basal	27	12.45	1.54	12.60	6.10	14.60
	end of study	27	13.62	2.38	13.50	6.80	19.70
Ht(%)	basal	27	37.24	4.81	38.30	17.10	43.50
	end of study	27	39.56	6.18	40.00	17.30	49.40
WBC(/mm3)	basal	25	6254.00	2801.04	6600.00	2200.00	13500.00
	end of study	26	5930.00	2528.08	5800.00	2600.00	15100.00
Plat(/mm3)	basal	26	236000.00	131970.75	210000.00	70000.00	531000.00
	end of study	26	211000.00	119184.64	184000.00	32000.00	428000.00
AST(U/L)	basal	26	89.42	65.21	69.50	15.00	301.00
	end of study	26	25.46	13.89	21.50	10.00	73.00
ALT(U/L)	basal	26	127.00	112.30	100.00	16.00	457.00
	end of study	26	37.00	25.58	33.50	7.00	105.00
GGT(U/L)	basal	26	85.98	105.20	50.75	15.00	530.00
	end of study	25	30.38	29.88	24.00	7.00	160.00
APhos(U/L)	basal	25	464.80	264.43	380.00	67.00	1054.00
	end of study	25	256.50	209.57	169.00	41.00	885.00
TB(g/dl)	basal	23	1.04	0.70	0.70	0.31	3.00
	end of study	23	0.85	0.51	0.79	0.11	2.20
DB(g/dl)	basal	23	0.45	0.40	0.30	0.05	1.70
	end of study	23	0.19	0.10	0.20	0.02	0.40
Alb(g/dl)	basal	19	3.79	0.93	3.80	1.50	5.30
	end of study	19	4.31	0.47	4.27	3.10	5.53
INR	basal	21	1.34	0.26	1.25	0.97	1.91
	end of study	21	1.24	0.21	1.14	1.01	1.68

Abbreviations: hemoglobin (HB) (g/dl), hematocrit (HT) (%), white cell count (WCC) (/mm3), Platelets (PLAT) (/mm3), aspartate aminotransferase (AST) (U/L), alanine transaminase (ALT) (U/L), gamma-glutamyltransferase (GGT) (U/L), alkaline phosphatase (APhos) (U/L), total bilirubin (TB) (mg/dl), albumin (Alb) (g/dl), international normalized ratio (INR).